Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy

Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+Cells as Advanced Therapy... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png BioMed Research International Unpaywall

Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy

Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy

Loading next page...
 
/lp/unpaywall/full-gmp-compliant-validation-of-bone-marrow-derived-human-cd133-cells-DgB0bLPoOL

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
2314-6133
DOI
10.1155/2015/473159
Publisher site
See Article on Publisher Site

Abstract

Journal

BioMed Research InternationalUnpaywall

Published: Jan 1, 2015

There are no references for this article.